Literature DB >> 18036370

Frequency and mechanism of persistent systolic anterior motion and mitral regurgitation after septal ablation in obstructive hypertrophic cardiomyopathy.

Francesca N Delling1, Danita Y Sanborn, Robert A Levine, Michael H Picard, Michael A Fifer, Igor F Palacios, Patricia A Lowry, Gus J Vlahakes, Mordehay Vaturi, Judy Hung.   

Abstract

Relief of obstruction using ventricular septal ablation (VSA) may not eliminate systolic anterior motion (SAM) of the mitral valve and mitral regurgitation (MR) in patients with obstructive hypertrophic cardiomyopathy. The hypothesis was that persistent SAM after VSA was secondary to anterior papillary muscle displacement and malcoaptation of mitral valve leaflets and that these findings could predict persistence of SAM. Echocardiograms were examined from 37 patients with obstructive hypertrophic cardiomyopathy before and 12+/-3 months after VSA. Anterior leaflet malposition (anterior-to-posterior leaflet coaptation position ratio), papillary muscle malposition (septal-to-lateral/left ventricular internal diameter ratio), and anterior position of coaptation relative to the septum (coaptation-to-septal distance) were assessed. MR proximal jet width was also measured. Of 37 patients, 30 underwent successful VSA (left ventricular outflow tract gradient reduction>50%); 22 of 30 and 7 of 7 with <50% reduction (total 29 of 37; 78%) showed persistent SAM at 12+/-3 months. These patients had more anterior malposition of the mitral valve and less MR reduction than those without SAM: anterior-to-posterior leaflet coaptation position ratio 0.42+/-0.06 versus 0.56+/-0.09, septal-to-lateral/left ventricular internal diameter ratio 0.39+/-0.12 versus 0.55+/-0.12, coaptation-to-septal distance 1.8+/-0.42 versus 2.8+/-0.30 cm, and MR reduction by 29+/-22% versus 71+/-12% (p<0.0001). Gradients, both at rest and provokable, were higher (27+/-33 vs 4+/-5 mm Hg, p=0.0004; >45 mm Hg in 9 vs 0, p=0.03, respectively) in patients with persistent SAM. Anterior malposition was present before VSA, with anterior-to-posterior leaflet coaptation position ratio<0.5 predicting SAM after VSA (p<0.0001). In conclusion, SAM and MR were often not eliminated using VSA. Mitral valve malposition was a strong predictor of SAM and MR reduction after VSA and may need to be considered in optimizing results of this procedure.

Entities:  

Mesh:

Year:  2007        PMID: 18036370     DOI: 10.1016/j.amjcard.2007.07.020

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

Review 1.  Mitral valve disease--morphology and mechanisms.

Authors:  Robert A Levine; Albert A Hagége; Daniel P Judge; Muralidhar Padala; Jacob P Dal-Bianco; Elena Aikawa; Jonathan Beaudoin; Joyce Bischoff; Nabila Bouatia-Naji; Patrick Bruneval; Jonathan T Butcher; Alain Carpentier; Miguel Chaput; Adrian H Chester; Catherine Clusel; Francesca N Delling; Harry C Dietz; Christian Dina; Ronen Durst; Leticia Fernandez-Friera; Mark D Handschumacher; Morten O Jensen; Xavier P Jeunemaitre; Hervé Le Marec; Thierry Le Tourneau; Roger R Markwald; Jean Mérot; Emmanuel Messas; David P Milan; Tui Neri; Russell A Norris; David Peal; Maelle Perrocheau; Vincent Probst; Michael Pucéat; Nadia Rosenthal; Jorge Solis; Jean-Jacques Schott; Ehud Schwammenthal; Susan A Slaugenhaupt; Jae-Kwan Song; Magdi H Yacoub
Journal:  Nat Rev Cardiol       Date:  2015-10-20       Impact factor: 32.419

Review 2.  Basic mechanisms of mitral regurgitation.

Authors:  Jacob P Dal-Bianco; Jonathan Beaudoin; Mark D Handschumacher; Robert A Levine
Journal:  Can J Cardiol       Date:  2014-07-02       Impact factor: 5.223

Review 3.  Management of systolic anterior motion of the mitral valve: a mechanism-based approach.

Authors:  Susumu Manabe; Hitoshi Kasegawa; Hirokuni Arai; Shuichiro Takanashi
Journal:  Gen Thorac Cardiovasc Surg       Date:  2018-04-03

4.  In vivo measurement of mitral leaflet surface area and subvalvular geometry in patients with asymmetrical septal hypertrophy: insights into the mechanism of outflow tract obstruction.

Authors:  Dae-Hee Kim; Mark D Handschumacher; Robert A Levine; Yun-Sil Choi; Yun Jeong Kim; Sung-Cheol Yun; Jong-Min Song; Duk-Hyun Kang; Jae-Kwan Song
Journal:  Circulation       Date:  2010-09-13       Impact factor: 29.690

Review 5.  Anatomy of the mitral valve apparatus: role of 2D and 3D echocardiography.

Authors:  Jacob P Dal-Bianco; Robert A Levine
Journal:  Cardiol Clin       Date:  2013-04-15       Impact factor: 2.213

6.  Diastolic leading to systolic anterior motion: new technology reveals physiology.

Authors:  Robert A Levine; Ehud Schwammenthal; Jae-Kwan Song
Journal:  J Am Coll Cardiol       Date:  2014-11-03       Impact factor: 24.094

7.  Does the Flow Know? Mitral Regurgitant Jet Direction and Need for Valve Repair in Hypertrophic Obstructive Cardiomyopathy.

Authors:  Ehud Schwammenthal; Albert A Hagège; Robert A Levine
Journal:  J Am Soc Echocardiogr       Date:  2019-03       Impact factor: 5.251

Review 8.  The mitral valve in hypertrophic cardiomyopathy: old versus new concepts.

Authors:  Albert A Hagège; Patrick Bruneval; Robert A Levine; Michel Desnos; Hany Neamatalla; Daniel P Judge
Journal:  J Cardiovasc Transl Res       Date:  2011-09-10       Impact factor: 4.132

Review 9.  Review of Contemporary Invasive Treatment Approaches and Critical Appraisal of Guidelines on Hypertrophic Obstructive Cardiomyopathy: State-of-the-Art Review.

Authors:  Steven Lebowitz; Mariusz Kowalewski; Giuseppe Maria Raffa; Danny Chu; Matteo Greco; Caterina Gandolfo; Carmelo Mignosa; Roberto Lorusso; Piotr Suwalski; Michele Pilato
Journal:  J Clin Med       Date:  2022-06-14       Impact factor: 4.964

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.